Evidence map›Paper›PMID 24632555›Full record

ArticleToxins2014

Zearalenone, an estrogenic mycotoxin, is an immunotoxic compound.

Isis M Hueza, Paulo Cesar F Raspantini, Leonila Ester R Raspantini, Andreia O Latorre, Silvana L Górniak

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 211 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Mycotoxins from Tomato PathogenicJournal of fungi (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Defense Mechanisms of CottonInternational journal of molecular sciences · 2022
    Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Isis M HuezaDivision of Pharmaceutical Sciences, Federal University of São Paulo (UNIFESP-Diadema), Diadema 09913-030, S.P., Brazil. imhueza@unifesp.br.
Paulo Cesar F RaspantiniDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Pirassununga 05508-270, S.P., Brazil. pcfr@usp.br.
Leonila Ester R RaspantiniDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Pirassununga 05508-270, S.P., Brazil. esterraspantini@usp.br.
Andreia O LatorreDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Pirassununga 05508-270, S.P., Brazil. andreia.latorre@gmail.com.
Silvana L GórniakDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Pirassununga 05508-270, S.P., Brazil. gorniak@usp.br.
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the toxic effects of zearalenone (ZEA) on the immune function. Ovariectomised rats were treated daily by gavage with 3.0 mg/kg of ZEA for 28 days. Body weight gain, food consumption, haemotological parameters, lymphoid organs, and their cellularities were evaluated. Moreover, acquired immune responses and macrophage activity were also assessed. ZEA promoted reduction in body weight gain, which is not fully explained by diminished food consumption. Despite no effect on haematological parameters, ZEA caused thymic atrophy with histological and thymocyte phenotype changes and decrease in the B cell percentage in the spleen. With respect to acquired and innate immune responses, no statistically significant differences in delayed-type hypersensitivity were noticed; however, in the ZEA-treated rats, antibody production and peroxide release by macrophages were impaired. The observed results could be related to ZEA activity on ERs; thus, ZEA is an immunotoxic compound similar to estrogen and some endocrine disruptors.

Indexed as

AnimalsB-LymphocytesBody WeightEatingErythrocytesEstrogens, Non-SteroidalFemaleImmunoglobulin MMacrophages, PeritonealOrgan SizeOvariectomyRatsRats, WistarSheepSpleenThymus GlandEstrogens, Non-SteroidalImmunoglobulin MZearalenone

Identifiers

PMID24632555
PMCPMC3968378
OpenAlexW2020479941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.